Introduction to A-Alpha Bio

This webinar, published by Digital World Biology, provides an introduction and overview to A-Alpha Bio, a "biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions." David Younger, CEO at A-Alpha Bio, discusses the company's history, work, and the systems it utilizes to predict protein-protein interaction (PPI). Covered is the PPI prediction process and the role of machine learning.